EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 9 June 2020. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 4.28 for January-March 2020 as against Tk. 3.69 for January-March 2019; Consolidated EPS was Tk. 12.44 for July 2019-March 2020 as against Tk. 11.15 for July 2018-March 2019. Consolidated NOCFPS was Tk. 10.13 for July 2019-March 2020 as against Tk. 10.57 for July 2018-March 2019. Consolidated NAV per share was Tk. 88.19 as on March 31, 2020 and Tk. 80.40 as on June 30, 2019.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b0000400570fb
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.